Your browser is no longer supported. Please, upgrade your browser.
Settings
MCK [NYSE]
McKesson Corporation
IndexS&P 500 P/E- EPS (ttm)-28.57 Insider Own0.10% Shs Outstand158.80M Perf Week0.29%
Market Cap30.75B Forward P/E9.44 EPS next Y20.72 Insider Trans-27.14% Shs Float158.06M Perf Month-0.80%
Income-4538.00M PEG- EPS next Q4.17 Inst Own89.90% Short Float0.99% Perf Quarter4.24%
Sales238.23B P/S0.13 EPS this Y-667.60% Inst Trans1.18% Short Ratio1.49 Perf Half Y9.41%
Book/sh-0.13 P/B- EPS next Y7.81% ROA-7.40% Target Price225.53 Perf Year33.39%
Cash/sh39.91 P/C4.90 EPS next 5Y10.06% ROE-167.50% 52W Range139.76 - 204.66 Perf YTD12.41%
Dividend1.68 P/FCF8.06 EPS past 5Y-37.30% ROI-61.00% 52W High-4.48% Beta0.88
Dividend %0.86% Quick Ratio0.60 Sales past 5Y4.50% Gross Margin5.10% 52W Low39.88% ATR4.50
Employees59000 Current Ratio1.00 Sales Q/Q1.00% Oper. Margin-2.10% RSI (14)52.20 Volatility1.87% 2.09%
OptionableYes Debt/Eq- EPS Q/Q-26.00% Profit Margin-1.90% Rel Volume0.90 Prev Close195.51
ShortableYes LT Debt/Eq- EarningsMay 06 AMC Payout- Avg Volume1.04M Price195.50
Recom1.80 SMA20-0.02% SMA500.85% SMA20011.03% Volume937,077 Change-0.01%
Mar-30-21Upgrade Argus Hold → Buy $230
Nov-02-20Upgrade Barclays Equal Weight → Overweight $166
Aug-04-20Upgrade Deutsche Bank Hold → Buy $202
May-22-20Upgrade Wolfe Research Peer Perform → Outperform
May-15-20Upgrade UBS Neutral → Buy $151 → $160
Apr-23-20Resumed Credit Suisse Neutral $146
Mar-18-20Upgrade Goldman Neutral → Buy $173 → $174
Mar-13-20Upgrade Guggenheim Neutral → Buy
Feb-07-20Upgrade Robert W. Baird Neutral → Outperform $197
Jan-10-20Upgrade Morgan Stanley Equal-Weight → Overweight $162
Sep-12-19Initiated Deutsche Bank Hold
Aug-05-19Downgrade Wolfe Research Outperform → Peer Perform
Jul-22-19Initiated Guggenheim Neutral $152
Jan-17-19Initiated UBS Neutral $134
Oct-26-18Reiterated Barclays Equal Weight $150 → $136
Jul-20-18Downgrade Robert W. Baird Outperform → Neutral
May-29-18Reiterated Leerink Partners Mkt Perform $170 → $160
Mar-08-18Initiated Barclays Equal Weight $165
Feb-27-18Resumed BofA/Merrill Buy
Feb-02-18Reiterated Mizuho Neutral $186 → $179
Jun-07-21 08:13AM  
May-17-21 07:00AM  
May-10-21 03:33AM  
May-07-21 03:46PM  
07:43AM  
06:00AM  
May-06-21 05:35PM  
04:05PM  
May-05-21 08:40AM  
May-04-21 04:03PM  
Apr-30-21 01:49PM  
10:30AM  
10:26AM  
Apr-29-21 04:10PM  
Apr-28-21 10:28AM  
Apr-15-21 08:14AM  
Apr-13-21 12:10PM  
Apr-12-21 12:17PM  
08:43AM  
04:51AM  
Apr-05-21 09:49AM  
07:27AM  
Apr-03-21 10:56AM  
Apr-01-21 04:10PM  
11:38AM  
09:13AM  
08:37AM  
Mar-31-21 09:15AM  
Mar-29-21 10:08AM  
Mar-26-21 11:50AM  
Mar-22-21 07:32PM  
Mar-15-21 09:15AM  
Mar-12-21 08:03AM  
Mar-11-21 09:47AM  
Mar-10-21 09:53AM  
Mar-09-21 11:50AM  
Mar-04-21 11:30AM  
09:17AM  
Mar-01-21 02:52PM  
10:55AM  
08:21AM  
06:17AM  
Feb-18-21 07:15AM  
Feb-02-21 02:00PM  
12:00PM  
10:25AM  
09:39AM  
08:25AM  
07:22AM  
07:14AM  
07:00AM  
Feb-01-21 10:55AM  
10:15AM  
Jan-29-21 09:05PM  
09:36AM  
Jan-28-21 04:10PM  
07:28AM  
Jan-27-21 10:10AM  
Jan-22-21 08:00AM  
Jan-21-21 03:39PM  
Jan-20-21 02:46PM  
Jan-15-21 12:10PM  
Jan-14-21 08:15AM  
07:20AM  
Jan-13-21 11:15AM  
09:45AM  
09:32AM  
Jan-12-21 11:41AM  
11:10AM  
Jan-11-21 09:48AM  
08:56AM  
03:38AM  
Jan-08-21 09:47AM  
Jan-05-21 12:18PM  
Jan-04-21 09:26AM  
Jan-01-21 11:50AM  
Dec-30-20 11:40AM  
Dec-29-20 08:00AM  
Dec-28-20 04:10PM  
12:18PM  
08:54AM  
Dec-27-20 12:10PM  
Dec-24-20 02:47PM  
10:00AM  
Dec-23-20 01:45PM  
06:54AM  
Dec-22-20 04:15PM  
Dec-21-20 04:41PM  
Dec-19-20 07:00AM  
Dec-18-20 05:17PM  
12:44PM  
Dec-16-20 11:50AM  
Dec-14-20 11:40AM  
10:57AM  
07:00AM  
Dec-11-20 08:20AM  
Dec-09-20 09:40AM  
Dec-08-20 07:03AM  
Dec-07-20 06:13PM  
12:22PM  
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and solutions for life sciences companies, including offering multiple distribution channels and clinical trial access to specific patient populations through its network of oncology physicians. The segment also sells financial, operational and clinical solutions to pharmacies; and offers consulting, outsourcing, and other services. The Prescription Technology Solutions segment operates in the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions. The International segment provides drug distribution services, specialty pharmacy, and retail and infusion care services. The Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rodgers Thomas LEVP, Chief Strategy & BDOJun 08Sale192.8519838,1841,161Jun 09 05:23 PM
Rodgers Thomas LEVP, Chief Strategy & BDOJun 05Option Exercise0.001,07201,638Jun 07 07:29 PM
Rodgers Thomas LEVP, Chief Strategy & BDOJun 01Sale189.5614527,486566Jun 02 06:31 PM
Schechter Lori A.EVP, Chief Legal Officer & GCJun 01Sale189.5612,9102,447,2200Jun 02 06:30 PM
Reddy Sundeep G.SVP & ControllerMay 30Option Exercise0.0090903,945Jun 02 06:35 PM
Vitalone Britt J.EVP & CFOMay 30Option Exercise0.001,427022,478Jun 02 06:34 PM
Rodgers Thomas LEVP, Chief Strategy & BDOMay 30Option Exercise0.008560989Jun 02 06:31 PM
Faber TracyEVP & Chief HR OfficerMay 30Option Exercise0.002,45908,394Jun 02 06:31 PM
Schechter Lori A.EVP, Chief Legal Officer & GCMay 28Sale194.161,580306,77312,910Jun 02 06:30 PM
Reddy Sundeep G.SVP & ControllerMay 26Option Exercise0.0033503,205May 28 06:05 PM
Faber TracyEVP & Chief HR OfficerMay 26Option Exercise0.001,56406,890May 28 06:04 PM
Schechter Lori A.EVP, Chief Legal Officer & GCMay 26Option Exercise0.002,328015,238May 28 06:01 PM
Vitalone Britt J.EVP & CFOMay 26Option Exercise0.002,904022,194May 28 06:02 PM
TYLER BRIAN S.Chief Executive OfficerMay 25Option Exercise0.0010,278041,848May 28 06:00 PM
Schechter Lori A.EVP, Chief Legal Officer & GCMay 25Sale199.731,828365,10612,910May 27 08:02 PM
Rodgers Thomas LEVP, Chief Strategy & BDOMay 25Sale199.73458,988133May 27 08:00 PM
Faber TracyEVP & Chief HR OfficerMay 23Option Exercise0.0062903,137May 25 05:37 PM
Vitalone Britt J.EVP & CFOMay 23Option Exercise0.001,10104,042May 25 05:38 PM
Reddy Sundeep G.SVP & ControllerMay 23Option Exercise0.001,57303,344May 25 05:33 PM
Faber TracyEVP & Chief HR OfficerMay 21Option Exercise0.0038502,602May 25 05:37 PM
Vitalone Britt J.EVP & CFOMay 21Option Exercise0.003,11704,168May 25 05:38 PM
Rodgers Thomas LEVP, Chief Strategy & BDOMay 21Option Exercise0.002600260May 25 05:36 PM
Schechter Lori A.EVP, Chief Legal Officer & GCMay 21Option Exercise0.002,70702,707May 25 05:36 PM
Reddy Sundeep G.SVP & ControllerMay 21Option Exercise0.0033801,872May 25 05:33 PM
TYLER BRIAN S.Chief Executive OfficerMay 21Option Exercise0.0010,260022,452May 25 05:32 PM
Faber TracyEVP & Chief HR OfficerMay 12Option Exercise183.372,500458,4254,601May 14 07:37 PM
Schechter Lori A.EVP, Chief Legal Officer & GCMay 10Option Exercise183.373,000550,1103,000May 11 06:22 PM
Schechter Lori A.EVP, Chief Legal Officer & GCMay 10Sale200.003,000600,0000May 11 06:22 PM
TYLER BRIAN S.Chief Executive OfficerMay 10Sale200.006,7981,359,60012,192May 11 06:17 PM
TYLER BRIAN S.Chief Executive OfficerApr 15Option Exercise183.375,5111,010,55224,501Apr 19 06:56 PM
TYLER BRIAN S.Chief Executive OfficerApr 15Sale191.415,5111,054,86118,990Apr 19 06:56 PM
TYLER BRIAN S.Chief Executive OfficerMar 15Option Exercise183.375,5111,010,55224,501Mar 16 04:40 PM
TYLER BRIAN S.Chief Executive OfficerMar 15Sale186.665,5111,028,68318,990Mar 16 04:40 PM
TYLER BRIAN S.Chief Executive OfficerFeb 16Option Exercise183.375,5101,010,36924,500Feb 17 05:27 PM
TYLER BRIAN S.Chief Executive OfficerFeb 16Sale183.385,5101,010,42418,990Feb 17 05:27 PM
Flores NancyEVP, CIO & CTOFeb 07Option Exercise0.005,43805,438Feb 09 06:54 PM
TYLER BRIAN S.Chief Executive OfficerJan 15Option Exercise183.375,5101,010,36924,500Jan 20 05:34 PM
Vitalone Britt J.EVP & CFOJan 15Option Exercise159.004,339689,9015,390Jan 20 05:37 PM
Vitalone Britt J.EVP & CFOJan 15Sale185.009,0571,675,5451,051Jan 20 05:37 PM
Reddy Sundeep G.SVP & ControllerJan 15Sale182.3245082,0441,534Jan 20 05:36 PM
TYLER BRIAN S.Chief Executive OfficerJan 15Sale184.325,5101,015,62418,990Jan 20 05:34 PM
Faber TracyEVP & Chief HR OfficerDec 15Sale174.0054695,0042,101Dec 16 07:08 PM
Vitalone Britt J.EVP & CFONov 04Option Exercise144.436,324913,37512,090Nov 05 05:18 PM
Faber TracyEVP & Chief HR OfficerNov 04Option Exercise0.0090102,710Nov 06 05:27 PM
Vitalone Britt J.EVP & CFONov 04Sale165.006,3241,043,4605,766Nov 05 05:18 PM
Vitalone Britt J.EVP & CFONov 03Option Exercise0.008,18109,229Nov 05 05:18 PM
Jacobs Christine MDirectorNov 03Sale160.001,157185,1200Nov 04 12:09 PM
COLES N ANTHONYDirectorAug 17Sale156.772,453384,5590Aug 19 03:35 PM
KNOWLES MARIE L/CADirectorAug 07Sale150.831,157174,5100Aug 10 05:39 PM